Funder
Takeda Pharmaceuticals U.S.A.
Takeda Pharmaceutical Company
NIMH
Reference14 articles.
1. The dismantling of a myth: a review of eating disorders and socioeconomic status;Gard;Int J Eat Disord,1996
2. What happens after treatment? A systematic review of relapse, remission, and recovery in anorexia nervosa;Khalsa;J Eat Disord,2017
3. Neurobiological model of the persistence of anorexia nervosa;Steinglass;J Eat Disord,2016
4. Could dopamine agonists aid in drug development for anorexia nervosa?;Frank;Front Nutr,2014
5. Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex;Zimmer;Neurosci Lett,2000